IRLAB Therapeutics AB (publ)

OM:IRLAB A Stock Report

Market Cap: SEK 168.2m

IRLAB Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:IRLAB A Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Nov 25BuySEK 499,999Joakim TedroffIndividual250,000SEK 2.00
20 Nov 25BuySEK 140,000Joakim TedroffIndividual70,000SEK 2.00
12 Nov 25BuySEK 120,000Joakim TedroffIndividual50,000SEK 2.40

Insider Trading Volume

Insider Buying: IRLAB A insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IRLAB A?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,204,2627.3%
Individual Insiders11,763,60813.8%
Institutions17,029,01720%
General Public49,941,13358.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 63.8%.

Top Shareholders

Top 25 shareholders own 41.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.75%
Avanza Fonder AB
4,881,319SEK 9.7m0%0.01%
5.3%
Daniel Johnsson
4,500,400SEK 8.9m0%no data
4.51%
Ancoria Insurance Public Ltd
3,826,638SEK 7.6m0%100.0%
4.32%
FV Group AB
3,665,626SEK 7.3m0%no data
4.12%
Fourth Swedish National Pension Fund (AP4)
3,495,420SEK 6.9m0%no data
2.35%
Unionen
2,000,000SEK 4.0m0%0.17%
2.21%
Nordnet Pensionsförsäkring AB
1,878,618SEK 3.7m0%0.05%
1.81%
Philip Diklev
1,534,507SEK 3.0m0%no data
1.42%
Marinvest Holding AB
1,208,250SEK 2.4m0%no data
1%
Joakim Tedroff
846,437SEK 1.7m77.7%no data
0.94%
Baretten Invest AB
800,000SEK 1.6m0%no data
0.89%
Clas Sonesson
757,535SEK 1.5m0%no data
0.88%
Nicholas Waters
745,146SEK 1.5m0%no data
0.82%
Lars-Erik Olsson
695,000SEK 1.4m0%no data
0.72%
Susanna Waters
613,650SEK 1.2m0%no data
0.71%
Claes Sandesjö
600,000SEK 1.2m0%no data
0.62%
Vic Tor AB
530,386SEK 1.1m0%no data
0.62%
Hans Victor
526,599SEK 1.0m0%no data
0.54%
Skandia Fonder AB
455,200SEK 901.3k0%no data
0.44%
Per Winberg
373,544SEK 739.6k0%no data
0.31%
Peder Svensson
261,925SEK 518.6k0%no data
0.3%
SEB Investment Management AB
251,161SEK 497.3k0%no data
0.28%
Viktor Siewertz
238,965SEK 473.2k0%no data
0.21%
FCG Fonder AB
177,902SEK 352.2k0%no data
0.071%
Storebrand Fonder AB,
60,000SEK 118.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/10 00:53
End of Day Share Price 2025/12/10 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IRLAB Therapeutics AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gonzalo Artiach CastanonABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Jyoti PrakashEdison Investment Research